for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover
Nature Medicine
Journal Prestige (SJR): 17.067
Citation Impact (citeScore): 17
Number of Followers: 776  
 
  Full-text available via subscription Subscription journal
ISSN (Print) 1078-8956 - ISSN (Online) 1546-170X
Published by NPG Homepage  [143 journals]
  • Author Correction: Thymosin α1 represents a potential potent
           single-molecule-based therapy for cystic fibrosis
    • Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

      Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis, Published online: 22 June 2018; doi:10.1038/s41591-018-0100-0

      Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisAuthor Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis, Published online: 2018-06-22; doi:10.1038/s41591-018-0100-02018-06-22
      DOI: 10.1038/s41591-018-0100-0
       
  • Publisher Correction: Stimulation of entorhinal cortex–dentate gyrus
           circuitry is antidepressive
    • Publisher Correction: Stimulation of entorhinal cortex–dentate gyrus circuitry is antidepressive

      Publisher Correction: Stimulation of entorhinal cortex–dentate gyrus circuitry is antidepressive, Published online: 22 June 2018; doi:10.1038/s41591-018-0084-9

      Publisher Correction: Stimulation of entorhinal cortex–dentate gyrus circuitry is antidepressivePublisher Correction: Stimulation of entorhinal cortex–dentate gyrus circuitry is antidepressive, Published online: 2018-06-22; doi:10.1038/s41591-018-0084-92018-06-22
      DOI: 10.1038/s41591-018-0084-9
       
  • Publisher Correction: Thymosin α1 represents a potential potent
           single-molecule-based therapy for cystic fibrosis
    • Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

      Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis, Published online: 22 June 2018; doi:10.1038/s41591-018-0099-2

      Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisPublisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis, Published online: 2018-06-22; doi:10.1038/s41591-018-0099-22018-06-22
      DOI: 10.1038/s41591-018-0099-2
       
  • Author Correction: STAT3 labels a subpopulation of reactive astrocytes
           required for brain metastasis
    • Author Correction: STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis

      Author Correction: STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis, Published online: 19 June 2018; doi:10.1038/s41591-018-0108-5

      Author Correction: STAT3 labels a subpopulation of reactive astrocytes required for brain metastasisAuthor Correction: STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis, Published online: 2018-06-19; doi:10.1038/s41591-018-0108-52018-06-19
      DOI: 10.1038/s41591-018-0108-5
       
  • Low-frequency cortical activity is a neuromodulatory target that tracks
           recovery after stroke
    • Low-frequency cortical activity is a neuromodulatory target that tracks recovery after stroke

      Low-frequency cortical activity is a neuromodulatory target that tracks recovery after stroke, Published online: 18 June 2018; doi:10.1038/s41591-018-0058-y

      Recovery of skilled motor function in rodents after stroke correlates with the restoration of low-frequency quasi-oscillatory activity in the motor cortex, and neuromodulatory electrical stimulation targeting this activity can further accelerate recovery.Low-frequency cortical activity is a neuromodulatory target that tracks recovery after stroke, Published online: 2018-06-18; doi:10.1038/s41591-018-0058-y2018-06-18
      DOI: 10.1038/s41591-018-0058-y
       
  • Publisher Correction: Targeting hepatic glutaminase activity to ameliorate
           hyperglycemia
    • Publisher Correction: Targeting hepatic glutaminase activity to ameliorate hyperglycemia

      Publisher Correction: Targeting hepatic glutaminase activity to ameliorate hyperglycemia, Published online: 12 June 2018; doi:10.1038/s41591-018-0047-1

      Publisher Correction: Targeting hepatic glutaminase activity to ameliorate hyperglycemiaPublisher Correction: Targeting hepatic glutaminase activity to ameliorate hyperglycemia, Published online: 2018-06-12; doi:10.1038/s41591-018-0047-12018-06-12
      DOI: 10.1038/s41591-018-0047-1
       
  • p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
    • p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells

      p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells, Published online: 11 June 2018; doi:10.1038/s41591-018-0050-6

      CRISPR–Cas9-induced DNA damage triggers p53 to limit the efficiency of gene editing in human pluripotent cells.p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells, Published online: 2018-06-11; doi:10.1038/s41591-018-0050-62018-06-11
      DOI: 10.1038/s41591-018-0050-6
       
  • Suppression of detyrosinated microtubules improves cardiomyocyte function
           in human heart failure
    • Suppression of detyrosinated microtubules improves cardiomyocyte function in human heart failure

      Suppression of detyrosinated microtubules improves cardiomyocyte function in human heart failure, Published online: 11 June 2018; doi:10.1038/s41591-018-0046-2

      Post-translational modification of microtubules by detyrosination is prevalent in failing human cardiomyocytes and inhibits cardiomyocyte contraction, suggesting a new therapeutic strategy for improving heart function.Suppression of detyrosinated microtubules improves cardiomyocyte function in human heart failure, Published online: 2018-06-11; doi:10.1038/s41591-018-0046-22018-06-11
      DOI: 10.1038/s41591-018-0046-2
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.158.208.189
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-